Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type
In the period 2009-2018, licensing and acquisition deals concerning oncology accounted for 29 percent of all therapeutic company licensing deals. This graph shows the share of total licensing and acquisition deals of therapeutic companies worldwide for the period from 2009 to 2018, by disease type.